US-based healthcare analytics platform developer Clarify Health completed a $150m series D round on Tuesday led by telecommunications group SoftBank’s Vision Fund 2 and backed by hospital operator Memorial Hermann Health System.
Funds and accounts managed by BlackRock filled out the participants in the round along with Insight Partners, Spark Capital, KKR, Aspenwood Ventures, Rivas Capital and Sigmas Group. It valued the company at $1.4bn according to Bloomberg.
Founded in 2015, Clarify has built an artificial intelligence (AI)-equipped enterprise analytics tool dubbed Atlas that helps care providers and insurers assess patients’ health conditions in a bid to identify suitable treatments and save costs.
Clarify chief executive Jean Drouin said: “To date, siloed, disparate data and systems have made it extremely difficult to build the trust and transparency needed to accelerate the shift to value.
“We finally have the AI-driven intelligence that healthcare organisations need to optimise every patient journey and embrace value-based arrangements across providers, payers and life sciences.”
Insight Partners, Spark Capital, Concord Health Partners and HWVP co-led the company’s $115m series C round, in March 2021, which included KKR, Rivas Capital and Sigmas Group.
Clarify had previously received $57m in a 2018 series B round led by KKR that came after $5.9m in funding from undisclosed backers two years earlier, according to securities filings.